首页> 外文期刊>The journal of clinical endocrinology and metabolism >Tumor Expression of Human Growth Hormone and Human Prolactin Predict a Worse Survival Outcome in Patients with Mammary or Endometrial Carcinoma
【24h】

Tumor Expression of Human Growth Hormone and Human Prolactin Predict a Worse Survival Outcome in Patients with Mammary or Endometrial Carcinoma

机译:人类生长激素和人类催乳激素的肿瘤表达预测乳腺癌或子宫内膜癌患者的生存率更差

获取原文
       

摘要

Context:Evidence suggests that human GH (hGH) and human prolactin (hPRL) possess an autocrine or paracrine oncogenic role in mammary and endometrial carcinoma. However, especially for hGH, the prognostic relevance of tumor expression of these hormones is not well defined.
机译:背景:证据表明,人GH(hGH)和人催乳素(hPRL)在乳腺癌和子宫内膜癌中具有自分泌或旁分泌致癌作用。然而,特别是对于hGH,这些激素的肿瘤表达的预后相关性尚未明确。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号